Handbook of Multiple Myeloma
Editat de Mohamad Mohty, Jean-Luc Harousseauen Limba Engleză Paperback – 27 iul 2015
Preț: 451.67 lei
Preț vechi: 475.44 lei
-5% Nou
Puncte Express: 678
Preț estimativ în valută:
86.45€ • 89.91$ • 72.44£
86.45€ • 89.91$ • 72.44£
Carte tipărită la comandă
Livrare economică 13-27 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319182179
ISBN-10: 331918217X
Pagini: 80
Ilustrații: XXII, 90 p. 4 illus.
Dimensiuni: 127 x 201 x 15 mm
Greutate: 0.13 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
ISBN-10: 331918217X
Pagini: 80
Ilustrații: XXII, 90 p. 4 illus.
Dimensiuni: 127 x 201 x 15 mm
Greutate: 0.13 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
V-ar putea interesa
-
Transfusion MedicineJeffrey McCullough-5%Preț: 723.04 lei761.09 lei -
-13%Preț: 329.91 lei379.66 lei -
Focus on Sickle Cell ResearchRalph L Plasmar-27%Preț: 697.01 lei948.52 lei -
Thrombohemostatic Disease ResearchViroj Wiwanitkit-27%Preț: 1301.18 lei1783.64 lei -
Transfusion Medicine in PracticeMichael J Desmond, MB, MRCP-18%Preț: 1100.56 lei1334.36 lei -
Manual for Blood ConservationD. Thomas-17%Preț: 162.74 lei195.78 lei -
La Transfusion Sanguine DemainPatrick Herve-13%Preț: 313.58 lei358.92 lei -
Etiology of Acute Leukemias in ChildrenJuan Manuel Mejía-Aranguré-5%Preț: 1166.49 lei1227.88 lei -
Sickle Cell Anemia: From Basic Science to Clinical PracticeFernando Ferreira Costa-5%Preț: 993.30 lei1045.58 lei -
Experimental Hematology TodaySiegmund J. Baum-5%Preț: 367.47 lei386.81 lei -
-5%Preț: 396.44 lei417.30 lei -
Die Erkrankungen der BlutdrüsenWilhelm Falta-5%Preț: 420.22 lei442.33 lei -
Technik der Blutgruppenbestimmung mit Einführung in die BlutgruppenpraxisFriedrich Pietrusky-5%Preț: 389.52 lei410.01 lei -
Hämatologische Zytologie der SpeicherkrankheitenH. G. Hansen-5%Preț: 516.41 lei543.60 lei -
-5%Preț: 373.00 lei392.64 lei -
Myeloische Metaplasie und fötale Blutbildung und deren HistogeneseHeinrich Fischer-5%Preț: 390.96 lei411.54 lei -
Transfusionsassoziierte PharmakotherapieGünter Singbartl-5%Preț: 338.19 lei355.99 lei
Public țintă
Professional/practitionerCuprins
Pathophysiology.- Diagnosis and staging.- Treatment of transplant eligible patients.- Treatment of elderly patients.- Treatment of relapsed patients.- Bone disease.
Notă biografică
Mohamad Mohty
Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty obtained his medical degree from the University of Montpellier, France and his PhD from the University of Marseille, France. Before moving to Paris, he was head of the Transplant Program at the University-Hospital of Nantes, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK. Professor Mohty’s translational research activity is focused on the pathophysiology of graft-vs-host disease and the immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as IMiDs and hypomethylating agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty is chairman of the Acute Leukemia Working Party (ALWP) and president-elect of the European Group for Blood and Marrow Transplantation (EBMT).He serves on the board of the EBMT and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology and EBMT. Professor Mohty has published more than 210 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals. He also serves as an Associate Editor for Leukemia, Bone Marrow Transplantation, European Journal of Haematology and Blood Cancer Journal, as a member of the editorial board of Haematologica and as a regular reviewer in different immunology, hematology and cancer journals such as Blood and The Lancet.
Jean-Luc Harousseau
Jean-Luc Harousseau is professor of hematology at the University of Nantes, France. He has been head of the Department of Clinical Haematology for 24 years and is now director of the Cancer Center René Gauducheau and president of the Institut du Cancer Nantes Atlantique at Nantes.
Professor Harousseau is a member of the Scientific Advisory Board of the French National Cancer Institute and president of the Clinical Research in Oncology National Committee. He was a founding member of the Groupe Ouest-Est Leucémies Aigues et Maladies du Sang and of the Intergroupe Français du Myélome and is currently president of this internationally renowned cooperative group. In addition, Professor Harousseau is a member of the European Haematology Association, the European Group for Blood and Marrow Transplantation, the American Society of Hematology and the American Society of Clinical Oncology, as well as the Scientific Advisory Board of Multiple Myeloma Research Foundation and the International Myeloma Foundation. Professor Harousseau has contributed to more than 400 peer-reviewed publications. His fields of interest are therapy of acute myeloid leukemia and multiple myeloma.
Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Professor Mohty obtained his medical degree from the University of Montpellier, France and his PhD from the University of Marseille, France. Before moving to Paris, he was head of the Transplant Program at the University-Hospital of Nantes, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK. Professor Mohty’s translational research activity is focused on the pathophysiology of graft-vs-host disease and the immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as IMiDs and hypomethylating agents. He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. Professor Mohty is chairman of the Acute Leukemia Working Party (ALWP) and president-elect of the European Group for Blood and Marrow Transplantation (EBMT).He serves on the board of the EBMT and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology and EBMT. Professor Mohty has published more than 210 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals. He also serves as an Associate Editor for Leukemia, Bone Marrow Transplantation, European Journal of Haematology and Blood Cancer Journal, as a member of the editorial board of Haematologica and as a regular reviewer in different immunology, hematology and cancer journals such as Blood and The Lancet.
Jean-Luc Harousseau
Jean-Luc Harousseau is professor of hematology at the University of Nantes, France. He has been head of the Department of Clinical Haematology for 24 years and is now director of the Cancer Center René Gauducheau and president of the Institut du Cancer Nantes Atlantique at Nantes.
Professor Harousseau is a member of the Scientific Advisory Board of the French National Cancer Institute and president of the Clinical Research in Oncology National Committee. He was a founding member of the Groupe Ouest-Est Leucémies Aigues et Maladies du Sang and of the Intergroupe Français du Myélome and is currently president of this internationally renowned cooperative group. In addition, Professor Harousseau is a member of the European Haematology Association, the European Group for Blood and Marrow Transplantation, the American Society of Hematology and the American Society of Clinical Oncology, as well as the Scientific Advisory Board of Multiple Myeloma Research Foundation and the International Myeloma Foundation. Professor Harousseau has contributed to more than 400 peer-reviewed publications. His fields of interest are therapy of acute myeloid leukemia and multiple myeloma.
Caracteristici
Up-to-date resource covering the existing and emerging practices in the diagnosis and management of multiple myeloma from distinguished experts
Features comprehensive analysis of the current treatment options for transplant eligible patients, elderly patients and relapsed patients as well as looking at treatment options for bone disease
Addresses an unmet need in the myeloma field for a handbook of this kind
Explores issues of vital interest to the research community
Includes supplementary material: sn.pub/extras
Features comprehensive analysis of the current treatment options for transplant eligible patients, elderly patients and relapsed patients as well as looking at treatment options for bone disease
Addresses an unmet need in the myeloma field for a handbook of this kind
Explores issues of vital interest to the research community
Includes supplementary material: sn.pub/extras